Report Description
mRNA Therapeutics and Vaccines Market Overview
Over the last two decades, medical researchers have been able to achieve proof-of-concept and demonstrate the viability of benefits of mRNA-based interventions. In fact, currently, there are more than 65 mRNA-based therapeutics and over 85 mRNA vaccines under development. In vitro transcribed mRNA is now being evaluated as a treatment option for several oncological and genetic disorders. Moreover, experts believe that the applications of this upcoming product class are potentially limitless. Synthetic mRNA can also be engineered to facilitate the in vitro development of several types of cell and gene therapies. For instance, it can be used to activate key molecular pathways in somatic cells in order to induce pluripotency, an important prerequisite for stem cell therapy. There are studies that describe the use of in vitro transcribed mRNA encoding novel designer nucleases to manipulate genetic material, which is a common practice in the development of advanced therapy medicinal products. Further, the COVID-19 pandemic has enabled medical researchers to realize the vast potential of mRNA-based vaccines. Contrary to traditional vaccinology, the aforementioned type of preventive interventions do not require the use of live (attenuated) pathogens, hence, are significantly less risky. Moreover, mRNA is expressed in the cytoplasm and does not enter cellular nuclei, implying that it is incapable of adversely interacting with the genome of patients. In this context, it is worth mentioning that the mRNA vaccines developed by Pfizer / BioNtech (COMIRNATY® / BNT-162) and Moderna (SpikeVax / mRNA-1273) against the novel coronavirus strain, were, for the first time in the history of vaccine development, developed and approved for use, in under a year.
Being a biomolecule, mRNA is well tolerated in vivo; however, despite its numerous benefits, there are several challenges that presently limit its use. Although recent advances in controlling translational efficacy and immunogenicity have led to the development of multiple viable pharmacological leads (a few of which are already approved for use), there are still several challenges that need to be addressed. One of the major concerns is related to the inherent instability, which significantly compromises in vivo persistence, of the molecule. In addition, the targeted in vivo delivery of this relatively fragile type of intervention is also complicated. Over the years, attempts to manipulate the chemical structure of mRNA have enabled therapy developers to engineer relative more stable versions of the molecule. Similarly, lipoplexes and lipid-based nanoparticles have been successfully used to administer mRNA-based vaccines. Given that many companies (most of which have fairly limited expertise) are now in pursuit of further improving this technology, and the fact that standards related to the safety and regulation of such interventions are subject to increasing stringency, the need for expert guidance on new molecular entity design and product development is paramount. Contemporary scientific expertise in mRNA, and its numerous applications, is backed by more than 20 years of dedicated research in this field. This primary objective of this report is to identify leading scientists and industry leaders in this domain and assess the impact of their contributions to the field, till date.
Scope of the Report
The “Key Opinion Leaders in mRNA Therapeutics and Vaccines” report features the identities of some of the key opinion leaders in this domain, offering a quantitative approach to assess the relative expertise of thought leaders in this subject, along with the means for aspiring therapy developers to contact such eminent personalities. The information in this report has been presented across two deliverables, namely an Excel sheet, featuring an interactive dashboard, and a PowerPoint deck, summarizing the ongoing activity in this domain, and key insights drawn from the available data. The report features the following details:
- Identities of Contemporary KOLs
An in-depth analysis of leading technical experts in the field of mRNA therapeutics and vaccines, featuring a quantitative assessment of all the available details across 30+ parameters related to individual KOLs, including the contact information (email ID, and links to their respective LinkedIn and ResearchGate profile, as well as other details) of those individuals who have publicly disclosed such details
- Assessment of Technical Expertise and Relative Impact on the Field of mRNA-based Interventions
An analysis of 25+ different (quantifiable) parameters, indicative of the expertise and impact created by different types of KOLs in this domain. The parameters considered in this analysis include inputs from publicly available information that describe experience, technical acumen, scientific activity, impact of contributions, strength of professional network, social media activity, and geographical location of individual KOLs
- KOL Competitiveness Analysis
A competitive benchmarking and valuation analysis, taking into account all available data on 25+ parameters that highlight the relative strength (technical expertise) and impact created on the industry, by individual KOLs
- KOL Profiles and Recent Activity Snapshots
Detailed profiles of top-ranking KOLs (according to our proprietary competitiveness analysis), featuring all available details, including (but not limited to) years of experience (both general and specific to mRNA-based research), educational qualifications, previous / current affiliations, previous / current designations, strength of professional networks (LinkedIn and ResearchGate), scientific activity (such as number of publications, and trials conducted), and contact information (as disclosed by individual KOLs in the public domain). In addition, this section includes brief snapshots of some of the recent contributions (such as publications, clinical trials conducted, keynote speeches delivered and posts on social media) of the KOLs captured in the report database, who have been profiled
Deliverable Outlines
Excel Deliverable
- The first section of the spreadsheet features details on the scope of the report and the inclusion and exclusion criteria taken into consideration during the data collection phase.
- The second section of the deliverable is a summary MS Excel dashboard, offering a detailed graphical perspective of the contemporary KOL landscape, featuring innovation and knowledge leaders, clinical research investigators, technical domain experts and industry leaders.
- The third section of the spreadsheet is an elaborate table, which provides information on the leading technical experts in the field of mRNA therapeutics and vaccines. It features all the available details (across 30+ parameters) related to individual KOLs, for whom the relevant details are available in the public domain.
PowerPoint Deliverable
- The first part of this deliverable features an executive summary of the key insights generated from an in-depth analysis of various KOLs who are engaged in conducting research on mRNA and / or the development of mRNA-based therapeutics and vaccines.
- The next section is a broad perspective on the various types of KOLs that have been captured in this report and details related to their experience (past / current) and the various contributions that they have made in the field of mRNA therapeutics and vaccines.
- The third section of the deliverable features an analysis of 17 different (quantifiable) parameters based on which we have developed an informed opinion on the relative strength of an individual KOL in this domain. The aforementioned parameters include inputs from publicly available information that describe the experience, technical acumen, strength of professional network, social media activity and geographical location, of individual KOLs.
- In this section of the deliverable, we have quantified and analyzed 10 different parameters to develop an informed opinion on the relative impact that an individual KOL has had in this domain. The aforementioned parameters include inputs from publicly available information that describe the scientific activity and impact of contributions of individual KOLs.
- Based on our understanding of the relative strength and impact on industry, an elaborate 2×2 matrix was plotted to assess the competitiveness of individual KOLs. From the matrix, all of the individuals with high strength and impact scores were separately inspected against the contributions that they have made so far, in this domain. Further, a cumulative score (which takes into account both the aforementioned parameters) was assigned to each KOL and compared to a similar numerical value, which reflects the relative expertise of a knowledge leader, from a reliable third-party source.
- Finally, the report features profiles of prominent KOLs who emerged from among the top-ranking individuals (based on relative strength and impact on industry) in our proprietary competitiveness analysis. Each profile features all available details on the various KOLs who have been captured in the report. Further, we have provided snapshots of some of the recent contributions (such as publications, clinical trials conducted, keynote speeches delivered and posts on social media) of the same individuals.
Contents
Table Of Contents
Excel Deliverable
1. Data Collection Guide
2. Summary Dashboard
2.1. Overview of KOL Landscape
2.2. KOL Competitiveness Analysis
2.3. Interactive KOL Summaries
2.3.1. KOL Strength Parameters
2.3.2. Impact on Industry Parameters
2.3.3. Contact Information
3. KOL Data
4. Appendix I: Pivot Tables
5. Appendix II: Country / Geography Codes
PowerPoint Deliverable
1. Context
2. Project Approach & Objectives
3. Executive Summary
4. Contemporary KOL Landscape
4.1. Distribution by Type of KOL
4.2. Geographical Distribution
5. Analysis of KOL Strength
5.1. Overview and Methodology
5.2. Evaluation based on Experience
5.3. Evaluation based on Technical Acumen
5.4. Evaluation based on Professional Network
5.5. Evaluation based on Social Media Activity
5.6. Evaluation based on Geographical Location
5.7. Assessment of Relative KOL Strength
6. Analysis of Impact on Industry
6.1. Overview and Methodology
6.2. Evaluation based on Scientific Activity
6.3. Evaluation based on Impact on Industry
6.4. Assessment of Relative Impact on Industry
7. KOL Competitiveness Analysis
7.1. Overview and Methodology
7.2. Analysis of Clinical Researcher Investigators in North America
7.3. Analysis of Clinical Researcher Investigators in Europe
7.4. Analysis of Clinical Researcher Investigators in Asia Pacific
7.5. Analysis of Clinical Researcher Investigators in Rest of the World
7.6. Analysis of Innovation and Knowledge Leaders in North America
7.7. Analysis of Innovation and Knowledge Leaders in Europe
7.8. Analysis of Innovation and Knowledge Leaders in Asia Pacific
7.9. Analysis of Industry Leaders in Rest of the World
7.10. Analysis of Industry Leaders in North America
7.11. Analysis of Industry Leaders in Europe
7.12. Analysis of Industry Leaders in Asia Pacific
7.13. Analysis of Industry Leaders in Rest of the World
7.14. Analysis of Technical Domain Experts in North America
7.15. Analysis of Technical Domain Experts in Europe
7.16. Analysis of Technical Domain Experts in Asia Pacific
7.17. Analysis of Technical Domain Experts in Rest of the World
8. KOL Profiles and Recent Activity Snapshots
8.1. KOL A (North America)
8.2. KOL B (North America)
8.3. KOL C (North America)
8.4. KOL D (North America)
8.5. KOL E (North America)
8.6. KOL F (Europe)
8.7. KOL G (Europe)
8.8. KOL H (Europe)
8.9. KOL I (Europe)
8.10. KOL J (Europe)
8.11. KOL K (Asia Pacific)
8.12. KOL L (Asia Pacific)
8.13. KOL M (Asia Pacific)
8.14. KOL N (Asia Pacific)
8.15. KOL N (Asia Pacific)
8.16. KOL O (Rest of the World)
8.17. KOL P (Rest of the World)
8.18. KOL Q (Rest of the World)
8.19. KOL R (Rest of the World)
8.20. KOL S (Rest of the World)
9. Appendices
List Of Companies
The following is an indicative list of companies and organizations that have been mentioned in the report. A more comprehensive list of 800+ companies / organizations is available on request
- A.O. Ospedale Papa Giovanni XXIII
- Aarhus University / Aarhus University Hospital
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Accent Therapeutics
- Advirna
- AIDS Healthcare Foundation CA US
- Ain Shams University
- Ajmera Transplant Centre UHN
- Albert Einstein College of Medicine
- Aldevron
- Allele Biotechnology
- Alnylam Pharmaceuticals
- Alnylam Pharmaceuticals
- AmpTech
- AMS Bio
- Anima Biotech
- ApeXBio
- Arcturus Therapeutics
- Arizona State University
- Arrakis Therapeutics
- ART Biosciences
- Asaf Harofeh Medical Center
- AskBio
- Assistance Publique - Hôpitaux de Paris
- Association Institut de Myologie
- Astrazeneca
- Atalanta Therapeutics
- Atlanta Therapeutics
- Auckland Clinical Studies (ACS)
- AvantiBio
- Avidity Biosciences
- Azienda Ospedaliero-Universitaria di Modena
- Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia
- Aztrazeneca
- Balgrist University Hospital
- Barbara Ann Karmanos Cancer Institute
- Barnsley Hospital NHS Foundation Trust UK
- Barts Health NHS Trust
- Beijing Friendship Hospital
- Beijing Institute of Technology
- Ben-Gurion University of the Negev
- Bharat Biotech
- Bharat Biotech International
- Biocad
- Biological Mimetics
- Biomay
- Bioneer
- BioNTech
- Biosynthesis
- Boehringer Ingelheim
- Boston Medical Centre
- Boston Scientific
- Boston University
- Boston University School of Medicine
- Boston's Children Hospital, Harvard Medical School
- California Institute Of technology
- Cancer Hospital, Chinese Academy of Medical Science
- Cancer Institute and Hospital Chinese Academy of Medical Sciences, NanJing PLA 81 Hospital
- Cancer Research UK Cambridge Institute (CRUCI)
- Cancer Science Institute, Singapore
- Cardiff University
- Carnegie Melon University
- Case Western Reserve University
- Case Western Reserve University
- CEA Paris
- Cellema
- Center for Clinical and Cosmetic Research
- Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine Mahidol University
- Central VetPharma Consultancy
- Centre For Genomic Regulation (CRG)
- Centre for Nutrition Research, University of Navarra
- Centre for Research in Agricultural Genomics (CRAG)
- Centre Henri Becquerel
- Centre Hospitalier De La Région D'Annecy
- Centre Hospitalier le Vinatier & CNRS UMR 5229 (BRON, France)
- Centre Hospitalier Lyon Sud, Lyon, France
- Centre Hospitalier Universitaire de Liège
- Centre Hospitalier Universitaire le Dantec (CHUD), Dakar, Senegal
- Centro Nacional de Investigaciones Oncológicas
- Changhai Hospital
- Charles University, Czech Republic
- Chicago Medical School, Rosalind Franklin University of Medicine and Science
- Children's Hospital of Philadelphia
- Children's Hospital, Helsinki University Hospital and the University of Helsinki
- Chimeron Bio
- China Medical University Hospital
- Chinese PLA General Hospital Beijing China
- Christchurch Clinical Studies Trust
- CHRU de Strasbourg
- CHU de Martinique
- CHU de Poitiers
- CHU SAINT-ETIENNE
- Chulalongkorn University
- CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III Madrid Spain
- CIBERES SEPAR
- City of Hope Medical Center
- City of Hope Medical Centre
- Click Biosystems
- Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Diseases (Medical Clinic II)
- Clinique Générale Beaulieu - Swiss International Prostate Center
- Coalition for Epidemic Preparedness Innovations (CEPI)
- Coca-Cola European Partners
- COG Phase I Consortium, Seattle Children's Hospital
- Cold Spring Harbor Lab
- Copehagen University Hospital Bispebjerg, Copenhagen
- Corpometria Institute
- Council for Scientific and Industrial Research, South Africa
- Creative Biolabs
- CureVac
- Daiichi Sankyo
- Dalhousie University
- Dana Farber Cancer Institute
- Danish Multiple Sclerosis Research Center
- Department of Internal Medicine, Asthma and Alergology, Barlicki Hospital, University Of Lodz
- Department of Surgery, National Taiwan University Hospital
- Diabetes Unit E. Wolfson Hospital
- Duke University
- Edith Wolfson Medical Center, Holon
- ElevateBio
- Eli Lilly
- Emory University
- Emory University
- Epidemiology Service, Local Health Authority of Reggio Emilia, Italy
- Essentia Health St. Joe's Medical Center
- ETH Zurich
- etheRNA
- Eurogentec
- European Molecular Biology Laboratory
- Expansion Therapeutics
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Formulate Bioscience
- Fred Hutchinson Cancer Research Center, University of Washington
- French Institute of Health and Medical Research
- French National Institute for Agriculture, Food, and Environment (INRAE)
- Friedrich Miescher Institute for Biomedical Research
- Fujita Health University Hospital
- Fundacion Infant, Argentina.
- Garvan Research Institute
- Gene Frontier Corporation
- Gennova
- Genome Institute Singapore
- Genomics, England
- George Washington University
- German Centre For Neurodegenrative Diseases (DZNE)
- Ghent University
- GlaxoSmithKilne
- Greater Paris University Hospitals - AP-HP
- GreenLight Biosciences
- Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)
- GSK Vaccines
- H. Lee Moffitt Cancer Center and Research Institute
- Hanmi Pharmaceutical
- Harvard Medical School
- Harvard University
- HDT Bio
- Hebei Medical University Third Hospital
- Hebrew University of Jerusalem
- Herlev and Gentofte Hospital, The Department of Orthopedics
- Hope Research Center
- Hôpital Européen Marseille
- Hôpitaux Universitaires de Strasbourg
- Hospices Civils de Lyon
- Hospices Civils de Lyon (Centre Hospitalier Universitaire de Lyon)
- Hospital Gregorio Marañon
- Hospital Korneuburg
- Hospital Sant Joan de Deu
- Hospital Universitari Vall d'Hebron
- Hospitales Universitarios Virgen del Rocío
- Howard Hughes Medical Institute
- Howard Hughes Medical Institute, Brandeis University
- Huazhong University of Science and Technology
- IBM Research
- Icahn School of Medicine at Mount Sinai
- Icahn School of Medicine at Mount Sinai
- ICON Early Phase Services
- Imperial College London
- Indonesia University
- Inland Norway University of Applied Sciences
- Innovation Forum
- Inovio Pharmaceuticals
- INSIGHT Copenhagen International Coordinating Centre, Rigshospitalet, University of Copenhagen
- Institució Catalana de Recerca i Estudis Avançats (ICREA)
- Institute Jacques Monod
- Institute of Molecular Biology, Academia Sinica
- Institute of Molecular Biotechnology, Vienna, Austria (IBMA)
- Institute of Molecular Medicine, Lisbon, Portugal
- Institute of Oncology Dr. Rosell (IOR)
- Institute of Sports Medicine, Copenhagen
- Instituto de Investigación Biomédica de Málaga (IBIMA)
- Instituto Mexicano del Seguro Social
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Instituto Nacional de Rehabilitación
- Instotut Curie
- Intellia Therapeutics
- International Vaccine Institute
- Ionis Pharmaceuticals
- IQVIA
- IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T)
- IRCCS Ospedale San Raffaele
- IVIRMA MADRID
- Janssen
- John Innes Centre
- Johns Hopkins Bloomberg School of Public Health
- Johns Hopkins University
- Joslin Diabetes Center
- Karolinska Institutet
- Karolinska Institutet Sweden
- Karolinska University Hospital Sweden
- Karolinska University Hospital, ME Infectious Diseases
- Kernal Biologics
- Kite Pharma
- KU Leuven
- KWF Kankerbestrijding
- Laboratoire Drouot
- Lake Pharma
- Landesklinikum Korneuburg, Vienna
- Laval University
- Leiden University Medical Center
- Lemonex
- Lemonex
- LifeEDIT
- Los Alamos National Laboratory
- Lucille P. Markey Cancer Center at University of Kentucky
- Lund University Hospital Swedwn
- M.D. Anderson Cancer Center
- Maastricht University
- Maastricht University Medical Center (MUMC+)
- Maastricht University Medical Centre
- Manchester Royal Infirmary
- Mansoura University
- Massachusetts General Hospital
- Matrivax Corporation
- Mayo Clinic
- McGill University
- McMaster University
- McMaster University, Department of Medicine, Division of Gastroenterology
- MEDES-IMPS
- Medical centrum Leeuwarden, Department of pulmonology
- Medical College of Wisconsin
- Medical University of South Carolina
- Medical University of Vienna
- Medisch Centrum Leeuwarden
- Memorial Sloan-Kettering Cancer Center
- Merck
- Mercurna
- Miescher Pharma
- MiNA Therapeutics
- Mischer Pharma
- Moderna Therapeutics
- Moffitt Cancer Center, USA
- Monash University
- Montreal Heart Institute
- MPI Brain Research, Germany
- MPI Germany
- MRC Laboratory of Molecular Biology
- Murdoch Children's Research Institute
- National and Kapodistrian University of Athens
- National Cancer Institute
- National Cardiovascular Center Harapan Kita Hospital Indonesia
- National Center of Neurology and Psychiatry, Japan
- National Institute of Rehabilitation, Mexico
- National Institute on Aging (NIA)
- National Institutes of Health
- National Kapodistrian University of Athens, Medical School
- National University Hospital, Singapore
- Necker University Hospital
- New York Langone Medical Center
- New York University Grossman School of Medicine, The Royal Melbourne Hospital
- Newcastle University
- n-Lorem
- North Texas Veterans Healthcare System Dallas VA Medical Center, University of Texas Southwestern
- NorthShore University HealthSystem, Greenville Health System
- Northwestern University
- Norwegian School of Sport Sciences
- Norwegian University of Science and Technology
- Novartis Vaccines
- Noxxon Pharma
- Nymirum
- Odense University Hospital
- Ohio State University
- Ohio State University Comprehensive Cancer Center
- OHSU Knight Cancer Institute
- Oncotherapeutics
- Oslo and Akershus university College
- Oslo Metropolitan University
- Oslo University Hospital
- OZ Biosciences
- Padjadjaran University
- Pantherna Therapeutics
- Penn State College of Medicine
- Penn State University
- Pennington Biomedical Research Center
- Pfizer
- phaRNA
- ProQR Therapeutics
- Protagonist Therapeutics
- Providence Therapeutics
- PT. Dankos Farma
- PTC Therapeutics
- Purdue University
- Quotient Clinical UK
- Rabin Medical Center
- Radboud University
- RD Biotech
- Recode Therapeutics
- Regeneron
- Reinier de Graaf Groep Netherlands
- Rejuvenation Technologies
- REXCELERATE
- RiboPro
- Rigshospitalet
- Rigshospitalet Denmark
- Rigshospitalet, Denmark
- RNACure
- RNAimmune
- Robert Wood Johnson Medical School/ Rutgers RWJMS Gout Center
- Rosalind Franklin University of Medicine and Science
- Roswell Park Cancer Institute
- Royal Papworth NHS Foundation Trust
- Royan Institute
- Ruijin Hospital Shanghai Jiao Tong University School of Medicine,
- Rutgers Cancer Institute of New Jersey
- Rutgers University, USA
- Rutgers, The State University of New Jersey
- San Gerardo Hospital
- San Raffaele Hospital, Italy
- Sanofi Pasteur Biologics
- Sarah Cannon Research Institute United Kingdom
- Scripps Research
- SEAMEO Regional Centre for Food and Nutrition
- Second Hospital of Shanxi Medical University
- Second Military Medical University, Shanghai
- Seoul National University
- Seoulin Biosciences
- Service des Maladies Infectieuses - Hôpital de la Croix Rousse - Hospices Civils de Lyon
- Shanghai BDgene
- Shanghai Changzheng Hospital
- Shanghai Jiao Tong University
- Shanghai Jiao Tong University School of Medicine
- Shengjing Hospital
- Sidney Kimmel Cancer Center at Thomas Jefferson University
- Singapore General Hospital
- SingHealth Investigational Medicine Unit (IMU)
- Siranomics
- South African Tuberculosis Vaccine Initiative University of Cape Town
- Spark therapeutics
- St. Jude Children's Research Hospital
- St. Vincent's Institute, Australia
- Stanford Cancer Institute
- Stanford University
- State University of New York at Buffalo
- Stemirna Therapeutics
- Steno Diabetes Center Copenhagen
- Stoke Therapeutics
- Storm Therapeutics
- Strand Therapeutics
- Surgical Department, Hospital of Southern Jutland, Denmark
- Synbio Technologies
- Tabriz University of Medical Sciences
- Taylor's University
- Technische Universität München
- Tehran University of Medical Sciences
- Tel Aviv University
- Temple University, Lewis Katz School of Medicine
- Texas Tech University Health Sciences Center
- Thai Red Cross
- the First-Affiliated Hospital of Sun Yat-Sen University
- The Francis Crick Institute
- The Hebrew University Jerusalem
- The Institute of Cancer Research/The Royal Marsden NHSFT
- The Newcastle Hospitals NHS Foundation Trust
- The Pirbright Institute
- The RNA Medicines Company
- The Rockefeller university
- The Scripps Research Institute, USA
- The First Affiliated Hospital of Sun Yat-Sen University
- The Sixth Affiliated Hospital, Sun Yat-sen University
- The Third Affiliated Hospital of Sun Yat-Sen University,
- The University of Hong Kong
- The University of Malaysia Medical Centre, Kuala Lumpur, Malaysia
- The University of Texas Health Science Center at Houston, Dept. of Medicine
- Thomas J. Watson Research Center
- Tiba Biotech
- Tongji Hospital
- Tongji University Affiliated Shanghai Pulmonary Hospital
- Translate Bio
- Translational Research Institute for Metabolism and Diabetes
- Trilink Biotechnologies
- Tropical Pesticides Research Institute, Tanzania
- Tsinghua University, China
- Turn Biotechnologies
- UC Davis Cancer Center
- UCSF Carol Franc Buck Breast Care Center
- Uganda Research Unit
- Ultimovacs
- Ultragenyx
- UNC Chapel Hill
- UNC Lineberger Comprehensive Cancer Center
- UNC Lineberger Comprehensive Cancer Center
- UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina
- Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
- Universidade Federal da Bahia
- Universitair Ziekenhuis Antwerpen
- Universitair Ziekenhuis Brussel
- Universitair Ziekenhuis Leuven
- Universitat Rovira I Virgili
- Universitätsspital Basel
- University At Albany
- University Children's Hospital Basel, UKBB
- University College London
- University Health Network, Toronto
- University Hospital Antwerp
- University Hospital Basel Switzerland
- University Hospital Brno
- University Hospital Brussels
- University Hospital Duesseldorf, Dept. for Hematology, Oncology and Clinical Immunology
- University Hospital Olomouc
- University Hospital, Antwerp
- University Hospital, Basel, Switzerland
- University Hospital, Clermont-Ferrand
- University Hospital, Rouen
- University Hospital, Strasbourg
- University Hospitals Coventry and Warwickshire NHS Trust
- University Hospitals, Case Comprehensive Cancer Center
- University Medical Center Groningen
- University of Aarhus
- University of Alabama at Birmingham
- University Of Amsterdam
- University of Antwerp, Laboratory of Experimental Hematology
- University Of Arizona
- University of Arizona, College of Nursing
- University of Bath
- University of Bern
- University Of Birmingham
- University of Brighton
- University of California
- University of California Irvine
- University of California Los Angeles
- University of California San Diego
- University Of California, Berkely
- University of California, Los Angeles
- University of California, Riverside
- University of California, San Diego
- University of California, San Francisco
- University of California, Santa Cruz
- University of Cambridge
- University of Campinas
- University of Chicago
- University Of Coimbra
- University of Cologne
- University of Colorado
- University of Colorado Anschutz Medical Campus
- University of Colorado Boulder
- University of Colorado, Denver
- University of Copenhagen
- University Of Doula
- University of East Anglia
- University of Edinburgh
- University of Electronic Science and Technology of China
- University of Florida
- University of Frankfurt
- University of Heidelberg
- University of Illinois
- University of Iowa
- University of Kansas Medical Center
- University of Kentucky
- University of Leipzig
- University Of Lethbridge
- University of Liège
- University of Limerick
- University of Liverpool
- University of Maryland
- University of Massachusetts Medical School
- University of Massachusetts, Worcester
- University of Miami
- University of Michigan
- University of Munich
- University of Navarra
- University of New Mexico Biochemistry & Molecular Biology
- University of North Carolina
- University of North Carolina, Chapel Hill
- University of Oslo
- University Of Oxford, UK
- University of Padau
- University of Pennsylvania
- University of Pennsylvania Institute for Translational Medicine and Therapeutics
- University of Pittsburgh
- University of Regensberg
- University of Rochester Medical Center, USA
- University of São Paulo
- University of Seville
- University of Southern California
- University Of Strasbourg
- University Of Sydney
- University Of Texas
- University of Texas Health Science Center at Houston
- University Of Texas, Southwestern Medical Centre
- University of Texas, Vanderbilt University
- University of Thessaly, School of Physical Education & Sport Science
- University of Tokyo
- University Of Torronto
- University of Tromso
- University of Tuebingen
- University of Utah
- University of Warsaw
- University of Washington
- University of Wisconsin
- University of York
- Univesitat Dresden
- UNSW, Sydney
- UPMC Magee Womens Hopspital
- Uppsala University
- UT Southwestern Medical Center
- VA Western New York Healthcare System, Buffalo, NY
- Vanderbilt University
- Vanderbilt University Medical Center
- Vastra Gotaland Region, Sahlgrenska University Hospital, dept. of Endocrinology
- Versameb
- VGXI
- Wageniningen University
- Wake Forest University
- Wallace H. Coulter Department of Biomedical Engineering.
- Walter Reed Army Institute of Research
- Walvax Biotechnology
- Washington University
- Weizmann Institute Of Science
- West China Hospital of Sichuan University
- Western University of Health Sciences
- Wolfson Medical Center
- Wright State Physicians Pharmacology Translational Unit
- Yale University
- Zealand University Hospital
- Ziphius Therapeutics
Source: www.cdc.gov/vaccines/covid-19/hcp/mrna.html
.PNG)
sales@rootsanalysis.com